Evidence map›Paper›PMID 35788572›Full record

ArticlePLoS neglected tropical diseases2022

Facility-based disease surveillance and Bayesian hierarchical modeling to estimate endemic typhoid fever incidence, Kilimanjaro Region, Tanzania, 2007-2018.

Elena R Cutting, Ryan A Simmons, Deng B Madut, Michael J Maze, Nathaniel H Kalengo, Manuela Carugati, Ronald M Mbwasi, Kajiru G Kilonzo, Furaha Lyamuya, Annette Marandu and 11 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Elena R CuttingDuke University School of Medicine, Division of Infectious Diseases and International Health, Durham, North Carolina, United States of America.
Ryan A SimmonsDuke Global Health Institute, Durham, North Carolina, United States of America.
Deng B MadutDuke University School of Medicine, Division of Infectious Diseases and International Health, Durham, North Carolina, United States of America.ORCID 0000-0003-4023-3928
Michael J MazeUniversity of Otago, Christchurch, New Zealand.
Nathaniel H KalengoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Manuela CarugatiDuke University School of Medicine, Division of Infectious Diseases and International Health, Durham, North Carolina, United States of America.
Ronald M MbwasiKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID 0000-0002-2365-5072
Kajiru G KilonzoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Furaha LyamuyaKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID 0000-0002-2319-8246
Annette MaranduMawenzi Regional Referral Hospital, Moshi, Tanzania.ORCID 0000-0002-3501-9591
Calvin MoshaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Wilbrod SagandaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Bingileki F LwezaulaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Julian T HertzDuke Global Health Institute, Durham, North Carolina, United States of America.ORCID 0000-0002-7396-4789
Anne B MorrisseyDuke University School of Medicine, Division of Infectious Diseases and International Health, Durham, North Carolina, United States of America.
Elizabeth L TurnerDuke Global Health Institute, Durham, North Carolina, United States of America.
Blandina T MmbagaDuke Global Health Institute, Durham, North Carolina, United States of America.ORCID 0000-0002-5550-1916
Grace D KinaboKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Venance P MaroKilimanjaro Christian Medical Centre, Moshi, Tanzania.
John A CrumpDuke University School of Medicine, Division of Infectious Diseases and International Health, Durham, North Carolina, United States of America.ORCID 0000-0002-4529-102X
Matthew P RubachDuke University School of Medicine, Division of Infectious Diseases and International Health, Durham, North Carolina, United States of America.ORCID 0000-0001-5262-1421

Funding

Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium-Expanding Diversity for Global Equity (EDGE)D43TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALIYU, MUKTAR HASSAN, HEIMBURGER, DOUGLAS CORBETT · 2017 to 2021
$6.3M
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
International Clinical Trials UnitU01AI062563 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2007
$4.0M
Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Viral Zoonoses and Severe Febrile Illness in Northern TanzaniaK23AI116869 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$896k
Biotechnology and Biological Sciences Research Council BB/J010367/1FIC NIH HHS D43 TW009337FIC NIH HHS R01 TW009237FIC NIH HHS R25 TW009337NIAID NIH HHS K23 AI116869NIAID NIH HHS R01 AI121378NIAID NIH HHS U01 AI062563
6 · The paper itself

Abstract

Growing evidence suggests considerable variation in endemic typhoid fever incidence at some locations over time, yet few settings have multi-year incidence estimates to inform typhoid control measures. We sought to describe a decade of typhoid fever incidence in the Kilimanjaro Region of Tanzania. Cases of blood culture confirmed typhoid were identified among febrile patients at two sentinel hospitals during three study periods: 2007-08, 2011-14, and 2016-18. To account for under-ascertainment at sentinel facilities, we derived adjustment multipliers from healthcare utilization surveys done in the hospital catchment area. Incidence estimates and credible intervals (CrI) were derived using a Bayesian hierarchical incidence model that incorporated uncertainty of our observed typhoid fever prevalence, of healthcare seeking adjustment multipliers, and of blood culture diagnostic sensitivity. Among 3,556 total participants, 50 typhoid fever cases were identified. Of typhoid cases, 26 (52%) were male and the median (range) age was 22 (<1-60) years; 4 (8%) were aged <5 years and 10 (20%) were aged 5 to 14 years. Annual typhoid fever incidence was estimated as 61.5 (95% CrI 14.9-181.9), 6.5 (95% CrI 1.4-20.4), and 4.0 (95% CrI 0.6-13.9) per 100,000 persons in 2007-08, 2011-14, and 2016-18, respectively. There were no deaths among typhoid cases. We estimated moderate typhoid incidence (≥10 per 100 000) in 2007-08 and low (<10 per 100 000) incidence during later surveillance periods, but with overlapping credible intervals across study periods. Although consistent with falling typhoid incidence, we interpret this as showing substantial variation over the study periods. Given potential variation, multi-year surveillance may be warranted in locations making decisions about typhoid conjugate vaccine introduction and other control measures.

Indexed as

Typhoid FeverTyphoid-Paratyphoid VaccinesBayes TheoremFemaleHumansIncidenceMaleSurveys and QuestionnairesTanzaniaTyphoid-Paratyphoid Vaccines

Identifiers

PMID35788572
PMCPMC9286265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.